GOLDMAN SACHS GROUP INC - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$2,083,555
-22.3%
2,062,926
-0.0%
0.00%
-100.0%
Q2 2023$2,681,835
+24.9%
2,062,950
-0.1%
0.00%
Q1 2023$2,147,488
+1.5%
2,064,892
-0.5%
0.00%
Q4 2022$2,115,756
+11035.6%
2,074,271
+14828.2%
0.00%
Q3 2022$19,000
-60.4%
13,895
-61.5%
0.00%
Q2 2022$48,000
-59.7%
36,126
+21.3%
0.00%
Q1 2022$119,00029,7920.00%
Other shareholders
VINCERX PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,658,199$2,189,0000.84%
Affinity Asset Advisors, LLC 1,374,098$1,814,0000.76%
SABBY MANAGEMENT, LLC 500,559$661,0000.45%
TANG CAPITAL MANAGEMENT LLC 1,030,634$1,360,0000.21%
Rubric Capital Management LP 2,107,000$2,781,0000.15%
Long Focus Capital Management, LLC 980,000$1,294,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$508,0000.09%
Clearline Capital LP 452,184$597,0000.08%
Sio Capital Management, LLC 102,049$135,0000.05%
Rock Springs Capital Management LP 814,194$1,075,0000.03%
View complete list of VINCERX PHARMA INC shareholders